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1. Introduction 
Exocortis or ‘scaly butt disease’ of citrus is distrib- 
uted world-wide [I]. The causative agent is citrus 
exocortis viroid (CEV) [2,3] which is a member of 
that unique group of plant pathogens, the viroids, of 
which only 8 have been described [ 1,4,5]. Like other 
members of the group, CEV consists of a single- 
stranded covalently closed circular RNA molecule 
which is highly base-paired, rod-like, infectious and 
non-encapsidated [ 1,4]. 
The primary sequence and proposed secondary 
structure of only 3 viroids have been reported so far: 
potato spindle tuber viroid (PSTV) with 359 residues 
[6]; chrysanthemum stunt viroid (CSV) with 356 
residues [7]; and avocado sunblotch viroid (ASBV) 
with 247 residues [8]. We report here the sequence 
and proposed secondary structure of the 371 residues 
of an Australian isolate of CEV and discuss the signif- 
icance of the extensive sequence homology which 
exists between PSTV, CSV and CEV. 
2. Materials and methods 
CEV (our strain A) was originally obtained from 
Dr R. van Velsen, South Australian Department of 
Agriculture, and propagated in chrysanthemum 
(Chrysanthemum morifolium cv. Bonnie Jean and 
Velvet Ridge), cuttings of which were kindly pro- 
vided by Dr R. K. Horst, Cornell University. Linear 
and circular CEV were purified as for CSV [9] and 
ASBV [s]. [T-~~P]ATP, [o-32P]dCTP and [cx-~~P]- 
dGTP were prepared as in [8,10]. 
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The sequencing of RNA fragments obtained by 
partial RNase digestion of viroids followed methods 
described fully in [7,8]. 
CEV was cloned as double-strand DNA under Cl 
containment conditions in the bacteriophage v ctor 
Ml 3 mp83 (kindly provided by Dr J. Messing) by an 
approach to be detailed elsewhere. Briefly, linear 
CEV was polyadenylated with poly(A) polymerase 
[ 1 I] and transcribed into double-strand DNA using 
reverse transcriptase and oligo(dT),c as the primer for 
fust-strand cDNA synthesis and self-priming for 
second-strand synthesis (Dr D. J. Kemp, personal 
communication). The product was cleaved with AZuI 
restriction endonuclease, the fragments purified by 
polyacrylamide gel electrophoresis and blunt-end 
ligated into the unique SmaI site of the replicative 
form of phage Ml3 mp83 using T4 DNA ligase [ 12, 
131. Phage and cells grown from the resultant white 
plaques obtained after transfection were screened for 
CEV inserts on nitrocellulose filters [ 14,151 using 
[5’-32P] CEV fragments generated by limited RNase 
U2 digestion of circular CEV [7]. Cloned CEV inserts 
were sequenced either by the Maxam and Gilbert 
method [ 161 or by use of the Ml3 specific primer 
GTABCGACG2C2AGT (Collaborative Res. Inc.) 
[ 121. A restriction enzyme fragment derived from the 
replicative form of the CEV insert was used as a 
primer for the sequencing of CEV by the dideoxy- 
nucleotide chain termination procedure [8,17]. 
3. Results 
3 .l . Sequencing procedure 
The approach used successfully for the sequenc- 
ing of CSV [7] and ASBV [8] was also used here. In 
brief, purified circular CEV was partially digested 
with RNases Ti, U2 and A and the exposed S’ends 
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labelled with [Y-~*P] ATP and T4 polynucleotide 
kinase. The 5’-labelled fragments were fractionated 
by size on an 80 cm long denaturing polyacrylamide 
slab gel, 20-30 labelled bands from each gel were 
eluted and sequenced using the partial enzymic 
cleavage method detailed in [7,8]. Almost the entire 
sequence of CEV was obtained from the large number 
of overlapping fragments sequenced on 7 M urea gels 
[7,8]. Four regions of band compression were resolved 
by use of gels containing 98% formamide [7]. How- 
ever, one region of band compression (residue no. 
186,187, fig.1) could not be resolved ue to its 
location -100 residues from the labelled 5’-terminus 
of the fragment containing it; this length exceeded 
the resolving capacity,of the gel system used. 
The sequence of CEV was finalised and much of 
the pre-determined sequence confirmed after cloning 
CEV via double-strand DNA in the bacteriophage 
vector Ml 3 mp83 [ 12,131. For example, acloned 
fragment (residues 252-362, fig.1) was sequenced by 
the dideoxynucleotide method with Ml3 universal 
primer [ 121 and by the Maxam and Gilbert method 
[ 161. In addition, a restriction endonuclease fragment 
(residues 272-329) derived from the cloned insert by 
hydrolysis with MspI was used as a primer for the 
dideoxynucleotide s quencing on the circular CEV 
[8]. This latter method gave a further 143 residues of 
readable sequence from the end of the primer and 
resolved the final 2 residues (186,187) which showed 
band compression of the direct RNA sequencing gels. 
A total of 2.53 residues were confirmed and sequenced 
using cloned CEV inserts. 
3.2. ISmary sequence and proposed secondav 
structure of CEV 
The complete base sequence of the 371 residues of 
CEV is given in fig.1 ;although CEV is circular, it is 
presented in linear form for convenience and for dis- 
cussion of possible translation products (see below). 
A secondary structure model was constructed (fig.2) 
to provide maximum sequence and structural homol- 
ogy with the proposed secondary structures of PSTV 
[6] and CSV [7]. The numbering of CEV residues 
follows the convention established for PSTV [6]. 
The numbers of the 3 types of base pairs for the 
proposed CEV structure are compared with the 
corresponding values for CSV, PSTV and ASBV 
(table 1). Although the percentages of residues base- 
CGGGAUC~UU~UUGAGGUUCCUGUGGUGCUCACCUGACCCUG~AGG~AGGAAAAGAAAAA -- 
l 10 20 30 40 50 60 
AGAGGCGGCGGGGGAAGAAGUCCUUCAGGGAUCCCCGGGGAAACCUGGAGGAAGUCGAGG 
61 70 60 90 100 110 120 
UCGGGGGGGACAGCUGCUUCGGUCGCCGCGGAUCACUGGCGUCCAGCGGAGAAACAGGAG 
121 130 140 150 160 170 180 
CUCGUCUCCUUCCUUUCGCUGCUGGCUCCACAUCCGAUCGUCGC~AGCGCCUCGCCCC 
101 190 200 210 220 239 240 
CUCGCCCGGAGCUUCUCUCUGGAGACUACCCGGUGGAAACAAC~AGCUUCAACCCCAA 
241 250 260 270 260 290 300 
ACCGCUUUUCUUGUAUCUUCACUGCUCUCCGGGCGAGGG~AAGCCCUCGGAACCC~ 
301 310 320 339 340 350 369 
AUUGGGUCCCU 
361 370 
Fig.1. Nucleotide sequence of CEV. The circular RNA is presented as a linear sequence with residue 1 corresponding to the left- 
hand end of the secondary structure model of fig.2. A bar beneath 3 residues indicates an titiation triplet and a bar above a 
sequence indicates a termination triplet. 
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Table 1 
Properties of proposed secondary structures for CEV, CSV, PSTV and ASBV 
Viroid No. of No. of base G:C base pairs Residues Ref. 
residues pairs as % of total base 
paired 
A:U G:C G:U 
CEV 371 34 72 18 58 67 This work 
csv 356 44 64 16 52 70 171 
PSTV 359 37 73 16 58 70 [61 
ASBV 247 43 28 12 34 67 181 
paired in the 4 structures are approximately the same, 
G:C base pairs make up a much lower proportion of 
the total in ASBV than in the other 3 viroids. 
The homologous equences shared by the 3 viroids 
CEV, CSV and PSTV are boxed in the structures of 
fig.2; 49% of CEV sequences are homologous with 
CSV and PSTV. The’most notable feature of the 
homologous regions are the 2 long conserved sequences 
in the centre of each molecule; 28 residues on the top 
(residue no. 83-l 10 in CEV) and 26 residues on the 
bottom (residue no. 265-290 in CEV). 
3.3. Possible polypeptide translation products of CEV 
Although CEV does not act as a messenger RNA in 
cell-free translation systems [181 and there is no evi- 
dence for the in vivo synthesis of viroid-specific pro- 
teins [ 191, it is feasible that sub-genomic linear frag- 
ments of CEV may act as mRNAs. Hence, possible start 
and stop codons have been marked on the linear sequence 
of fig.1, while the positions of the start and stop codons 
in both the plus strand of CEV (the infectious trand) 
and the complementary minus strand are listed in 
table 2 together with potential polypeptide products. 
Of the 10 start codons, only one of these is AUG 
and this occurs in the minus strand. There are 4 
potential polypeptide products coded for bythe plus 
strand (varying in length from 4-37 residues) and 
5 potential products coded for by the minus strand 
(15-87 residues). UGA is the major stop codon 
whiie UAA is not used at all (table 2). 
Table 2 
Start and stop codons in plus and minus strands of CEV and potential 
polypeptide translation products 
Residue number at 1st residue 
Start codons Stop codons 
AUG GUG UAA UAG 
Polypeptide product 
(amino acid residues) 
UGA 
Plus 23 35 4 
strand 26 35 3 
273 13 37 
339 13 15 
225 - 
284 - 
340 - 
358 - 
Minus 213 87 42 
strand 322 268 18 
211 321 87 
156 87 23 
33 359 15 
The residue numbers in the plus strand (infectious viroid) are retained in the minus 
strand; hence, residue numbers in the minus strand run in the 3’ to 5’ direction 
291 
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4. Discussion 
The sequence,of 371 residues for CEV represents 
the largest sequence so far reported for a viroid (table 
1). Its primary sequence and proposed secondary 
structure show striking regions of homology with the 
sequences and proposed secondary structures of 
PSTV and CSV (fig.2). Although 49% of CEV residues 
are homologous with PSTV and CSV in the structures 
of fig.2, there are additional sequences ofCEV present 
in PSTV and not CSV and vice versa. Thus, 59% of 
CEV sequences are homologous with PSTV and 60% 
with CSV. The data are consistent with the suggestion 
[8] that there exists a group of viroids which share 
common sequences and secondary structures and 
which may have evolved from a common ancestral 
viroid. The highly conserved central region of PSTV, 
CSV and CEV (fig.2), which is also present in the 
4 RNAs of cadangcadang viroid (Haseloff, Mohamed 
and Symons, unpublished), isintriguing and may 
represent a region essential for the replication of these 
viroids. However, very little of this central region is 
conserved inthe sequence ofASBV [B] which indicates 
that it should be allocated to a separate viroid group. 
The approaches used for sequencing CEV were the 
same as those used for ASBV [8] and CSV [7]. Direct 
sequencing of 5’-32P-labelled viroid fragments, pre- 
pared after partial RNase digestion, by the partial 
enzymic cleavage method rapidly yielded sequence 
data. However, a large number of fragments had to be 
sequenced to generate the necessary overlaps to com- 
plete the circular sequence since some fragments were 
poorly represented in the partial RNase digests. In 
addition, repeat digests were needed to resolve the occa- 
sional ambiguity in distinguishing C and U residues. 
The difficulty in finding poorly represented 
regions of the viroid in partial RNase digests is the 
limiting factor in the rapid sequencing of viroids 
by the partial enzymic cleavage method, but it can 
be overcome by the additional approach reported 
here. Thus, sequence data derived by direct sequenc- 
ing was used to predict restriction enzyme sites in 
double-strand DNA transcribed from CEV. DNA 
restriction fragments were then prepared and cloned 
into the replicative form of the bacteriophage Ml 3 
[ 121. The cloned inserts were sequenced irectly 
using a universal Ml3 DNA primer or after isolation 
from the double-strand repllcative form by the 
chemical method of Maxam and Gilbert [12,16,17]. 
Furthermore, the cloned CEV inserts could be further 
292 
restricted to generate specific DNA primers to prime 
dideoxynucleotide s quencing reactions on the viroid 
RNA to further extend the sequencing data. This 
additional approach using cloned viroid sequences thus 
allowed the complete sequence of CEV to be flnalised 
and also provided further confirmation of 68% of the 
sequence data obtained by direct RNA sequencing. 
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